This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Asian Americans remain persistently underrepresented as participants in medical research. Previous studies have found that Asian Americans are less willing to participate in healthresearch compared to other racial/ethnic groups. If you enjoy this content, please share it with a colleague
Findings from an observational analysis of ARISE-HF trial participants, newly-published in the Journal of the American College of Cardiology, JACC, shed light on the racial and ethnic disparities in diabetic cardiomyopathy (DbCM), which researchers note may have the potential to inform clinical practice, interventions, and policies.
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Cardiovascular health (CVH) is affected by genetic, social, and genomic factors across the life course, yet little research has focused on the interrelationships among them.
Taylor's, MD, FACC, pioneering career in cardiovascular medicine has been characterized by a lot of change, but his commitment to improving the health of all patients has remained constant, thanks in part to his grandmother who reminded him early in his career that health is one of life's greatest blessings.
Furthermore, there is growing interest in better understanding the mechanistic underpinnings of DFUs to better define personalized medicine to improve outcomes.
Cardiometabolic Health Congress faculty member, Fátima Rodriguez, MD, MPH, has committed much of her clinical and research efforts to reducing healthdisparities in Hispanic-American communities. Taub and Stanford for a panel discussion on improving health in women through lifestyle and therapeutic strategies.
Background:The prevalence of risk factors for heart failure and outcomes varies across racial and ethnic groups. This lack of diversity may exacerbate healthdisparities by not adequately addressing the unique clinical characteristics and responses to therapy.
The nine-module learning experience addresses lifestyle, pharmacotherapy and care delivery considerations for obesity, type 2 diabetes, hypertension, cardiovascular and chronic kidney disease, dyslipidemia, as well as a special module on reducing cardiometabolic healthdisparities in racial and ethnic minority populations.
The Society for Cardiovascular Angiography & Interventions (SCAI) kicks off its SCAI Scientific Sessions 2024 this week, May 2-4 in Long Beach, CA, bringing together more than 1,800 clinicians, scientists, researchers, and innovators in the field of interventional cardiology and endovascular medicine. Sinai Hospital (New York, NY).
The existence of structural racism creates a barrier to equitable access to health care and as a result is a fundamental driver of healthdisparities in the U.S., Generational socioeconomic adversity, especially among diverse racial and ethnic groups in the U.S., is tied to structural discrimination. - The statement issued Jan.
Background:There is mounting evidence that sexual and gender minority (SGM) groups experience healthdisparities, but research on brain health status of this underrepresented group is limited. The primary outcome was a composite of stroke, dementia, and late-life depression. non-binary) and transgender.
Background:There is mounting evidence that sexual and gender minority (SGM) groups experience healthdisparities, but research on brain health status of this underrepresented group is limited. The primary outcome was a composite of stroke, dementia, and late-life depression. non-binary) and transgender.
“We are reminded of the stark reality that Black Americans continue to face significant disparities in cardiovascular outcomes,” Mieres said. Social determinants of health have a detrimental impact in creating barriers that prevent the most vulnerable Americans from receiving the cardiovascular care they need.
This rise exacerbates the burden on overstretched cardiologists, who are facing a multitude of challenges like clinician shortages, complex workflows, administrative burden, poor patient adherence, healthdisparities and cost pressure. This immediacy in access to clinical support significantly impacts patient outcomes.
Abstract The limited literature and increasing interest in studies on cardiac electrophysiology, explicitly focusing on cardiac ion channelopathies and sudden cardiac death in diverse populations, has prompted a comprehensive examination of existing research.
Research shows that social determinants of health (SDOH) may influence this process by addressing underlying factors contributing to healthdisparities. The primary outcome was the reduction in systolic BP (RSBP) from baseline to the follow-up. years, with 52.6%
For cardiologists, this evidence reinforces the need to address the social determinants of health as a clinical priority, reshaping care strategies to bridge these deadly divides. The researchers assessed life expectancy trends between 2000 and 2021. Says Melvin R.
We can trace the roots of this misconception back to 1948 with the start of the long-term, ongoing Framingham Heart Study , which wrongly attributed age and sex of heart disease risks to only men in their 30s and 40s, cementing heart disease as a man’s disease and putting gender blinders on further research and treatment.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content